Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Open Label, Randomized Trial of AMG 706 or Bevacizumab in Combination with Paclitaxel and Carboplatin for Advanced Non-squamos Non-small Cell Lung Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date01/18/0810/10/09

Funding

  • Amgen Incorporated: $6,500.00